Akero Therapeutics (AKRO) Tops Q2 EPS by 2c
Tweet
Share
E-mailGet Alerts AKRO Hot Sheet
Join SI Premium – FREE
Akero Therapeutics (NASDAQ: AKRO) reported Q2 EPS of ($0.81), $0.02 better than the analyst estimate of ($0.83).
For earnings history and earnings-related data on Akero Therapeutics (AKRO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Getty Realty (GTY) Reiterated at Market Outperform by Citizens on Investment Volumes
- UBS Downgrades NAVER Corp. (035420:KS) (NHNCF) to Neutral
- Worthington Industries (WOR) Tops Q1 EPS by 7c
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
